# Grifols Biologicals LLC – FDA Inspection, Aug 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/7d95babc-3ded-46f0-acd7-59b29a125b36
Source feed: FDA_Inspections

> FDA inspection 1030300 of Grifols Biologicals LLC, August 22, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030300
- Company Name: Grifols Biologicals LLC
- Inspection Date: 2017-08-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1239092 - 2024-09-10](https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/ef61cb14-0dd8-4b4b-abad-0405939df44a)
- [FDA Inspection 1107183 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/b76dd2e2-5521-4e67-a44f-372ef07735fa)
- FDA Inspection 1088272 - 2019-01-31
- FDA Inspection 945099 - 2015-10-16

## Related Officers

- [Gene D. Arcy](https://www.keypedia.com/people/gene-d-arcy/a2def947-65fb-4056-84e2-1f89cf944cf0)

Company: https://www.keypedia.com/companies/grifols-biologicals-llc/206a08df-1e93-4280-b926-83661b2bb985

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
